Key Points
- Director Sheryle Bolton purchased 10,000 shares of Tivic Health Systems on April 15 at an average price of $1.04 per share (total value ~$10,400), a transaction disclosed in an SEC filing that leaves her owning 10,000 shares.
- Tivic is a very small-cap company (market cap ~$3.25 million) that reported a -$1.03 EPS last quarter, shows a wide one‑year price range ($0.72–$13.23) and currently carries an average analyst rating of "Sell" (Weiss Ratings reissued a sell).
Tivic Health Systems, Inc. (NASDAQ:TIVC - Get Free Report) Director Sheryle Bolton purchased 10,000 shares of the business's stock in a transaction on Wednesday, April 15th. The stock was purchased at an average price of $1.04 per share, with a total value of $10,400.00. Following the purchase, the director owned 10,000 shares of the company's stock, valued at approximately $10,400. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Tivic Health Systems Stock Performance
Shares of TIVC stock opened at $1.13 on Tuesday. The stock has a market cap of $3.25 million, a P/E ratio of -0.17 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a current ratio of 20.13 and a quick ratio of 20.13. The company has a fifty day moving average price of $0.92 and a two-hundred day moving average price of $1.58. Tivic Health Systems, Inc. has a one year low of $0.72 and a one year high of $13.23.
Tivic Health Systems (NASDAQ:TIVC - Get Free Report) last announced its quarterly earnings results on Monday, March 30th. The company reported ($1.03) earnings per share for the quarter, topping analysts' consensus estimates of ($408.00) by $406.97.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of Tivic Health Systems in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of "Sell".
Check Out Our Latest Research Report on Tivic Health Systems
About Tivic Health Systems
(
Get Free Report)
Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company's solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.
The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
